Ginger caplets in Post operative nausea and vomiting
Phase 3
- Conditions
- Health Condition 1: null- Post operative nausea and vomiting
- Registration Number
- CTRI/2012/10/003063
- Lead Sponsor
- The Himalaya Drug Company
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 50
Inclusion Criteria
•Patients who are posted for abdominal surgery, hernia, orthopedic and gynecological surgeries and also those patients presenting with Post operative nausea & vomiting.
•Patients willing to sign informed consent.
Exclusion Criteria
•Patients with severe vomiting related to CNS or severe gastrointestinal disorders.
•Any evidence or history of hypersensitivity to herbal medicines.
•Not willing to sign the informed consent or abide by the study procedure.
•Pregnant or lactating women
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method symptomatic relief from clinical symptoms of post operative nausea and vomitingTimepoint: Assessment is done at entry day 3 day 6 and day 10
- Secondary Outcome Measures
Name Time Method To assess the safety profile of Ginger caplets and overall complianceTimepoint: Assessment is done at entry day 3 day 6 and day 10